TBP and chronic kidney disease: In CKD 5 patients undergoing dialysis therapy (CKD 5D), median NQO1 gene expression was numerically higher than that in healthy controls but this was significant only for the NQO1/TBP ratio (a 2.6-fold increase for NQO1/TBP, p < 0.05, Figure 1(b)).